Pronota Company

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.
Technology: Cardiovascular Disorders Diagnostics
Industry: Deep Diagnostics
Headquarters: Ghent, Oost-Vlaanderen, Belgium
Founded Date: 18.10.2004
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 10
Total Funding: $41.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Series C

Visit Website
Register and Claim Ownership